Meet POSVAX, Discover the Biz Opportunity

• Report this article

POSVAX

POSVAX

Biopharmaceutical company based on the VLP (Virus-Like Particle) platform technology

Published May 2, 2024

+ Follow

POSVAX hopes to meet potential business partners at the partnering program of BIO KOREA 2024.

To view or add a comment, sign in

More articles by this author

No more previous content

• Dr. Hong-Jin Kim, CEO of POSVAX receives Prime Minister's Commendation... Development of the first domestic HPV 9-valent vaccine

  Jan 10, 2024

No more next content